A. Boulle

发表

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts.

M. Egger, F. Dabis, P. Braitstein, 2005, International journal of epidemiology.

Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study

M. Egger, M. May, M. Davies, 2017, PLoS medicine.

Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy

A. Boulle, U. Mehta, A. Heekes, 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings.

Matthias Egger, Christopher Bailey, Olivia Keiser, 2008, Bulletin of the World Health Organization.

A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment

F. Tanser, R. Wood, M. Davies, 2015, Journal of the International AIDS Society.

Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study

L. Myer, M. Egger, R. Wood, 2012, PLoS medicine.

Population‐wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis

N. Ford, A. Boulle, E. Goemaere, 2020, Journal of the International AIDS Society.

HIV programmatic outcomes following implementation of the ‘Treat‐All’ policy in a public sector setting in Eswatini: a prospective cohort study

A. Boulle, I. Ciglenecki, M. Schomaker, 2020, Journal of the International AIDS Society.

Long‐term virologic responses to antiretroviral therapy among HIV‐positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis

M. Davies, A. Boulle, M. Cornell, 2020, Journal of the International AIDS Society.

Quantifying the HIV treatment cascade in a South African health sub‐district by gender: retrospective cohort study

A. Boulle, M. Cornell, Mariette Smith, 2019, Tropical medicine & international health : TM & IH.

Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015

N. Ford, A. Boulle, G. Meintjes, 2019, Southern African journal of HIV medicine.

Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa.

A. Boulle, D. Coetzee, E. Goemaere, 2016, International journal of epidemiology.

Prospects for HIV control in South Africa: a model-based analysis

L. Myer, L. Bekker, M. Davies, 2016, Global health action.

Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?

O. Keiser, M. Davies, A. Boulle, 2014, American journal of epidemiology.

Mortality Among Adults Transferred and Lost to Follow-up From Antiretroviral Therapy Programmes in South Africa: A Multicenter Cohort Study

L. Myer, A. Boulle, M. Fox, 2014, Journal of acquired immune deficiency syndromes.

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

L. Myer, M. Egger, F. Dabis, 2008, Bulletin of the World Health Organization.

Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality

Colin Mathers, Matthias Egger, François Dabis, 2009, PLoS medicine.

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration.

B. Eley, R. Wood, M. Davies, 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

N. Ford, G. Maartens, A. Boulle, 2010, AIDS.

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007

L. Myer, M. Egger, R. Wood, 2010, AIDS.

Correcting for Mortality Among Patients Lost to Follow Up on Antiretroviral Therapy in South Africa: A Cohort Analysis

N. Ford, A. Boulle, D. Coetzee, 2011, PloS one.

Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy

C. Yiannoutsos, M. Egger, B. Musick, 2012, Sexually Transmitted Infections.

Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART Programmes in Sub-Saharan Africa

J. Sterne, C. Yiannoutsos, M. Egger, 2010, PloS one.

Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies

M. Egger, J. Mossong, R. Wood, 2013, PLoS medicine.

LIFE EXPECTANCIES OF HIV-POSITIVE ADULTS RECEIVING ANTIRETROVIRAL TREATMENT IN SOUTH AFRICA

M. Egger, J. Mossong, O. Keiser, 2012 .

Tenofovir in Second-Line ART in Zambia and South Africa: Collaborative Analysis of Cohort Studies

M. Egger, R. Wood, G. Wandeler, 2012, Journal of acquired immune deficiency syndromes.

Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey

A. Boulle, G. van Cutsem, S. Steele, 2019, PloS one.

When best practice is bad medicine: a new approach to rationing tertiary health services in South Africa.

N. Ford, A. Boulle, C. Kenyon, 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records

N. Tiffin, C. Lund, C. Orrell, 2020, The Lancet. Global health.

Feasibility of Establishing HIV Case-Based Surveillance to Measure Progress Along the Health Sector Cascade: Situational Assessments in Tanzania, South Africa, and Kenya

J. Hargreaves, A. Boulle, S. Xueref, 2017, JMIR public health and surveillance.

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.

A. Boulle, E. Goemaere, G. van Cutsem, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa

N. Ford, A. Boulle, G. van Cutsem, 2010, Journal of the International AIDS Society.

Assessing efficiency and costs of scaling up HIV treatment

D. Mcintyre, A. Boulle, S. Cleary, 2008, AIDS.

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

G. Maartens, A. Boulle, D. Coetzee, 2004, AIDS.

Viewpoint Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa

G. Rutherford, M. Egger, J. Hargreaves, 2019 .

Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa

G. Rutherford, M. Egger, J. Hargreaves, 2018, JMIR public health and surveillance.

Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data.

Brian G. Williams, N. Ford, A. Walker, 2021, The lancet. HIV.

The effects of HIV self-testing on the uptake of HIV testing, linkage to antiretroviral treatment and social harms among adults in Africa: A systematic review and meta-analysis

A. Boulle, C. Mathews, Damian J. Damian, 2021, PloS one.

The effects of HIV self-testing on the uptake of HIV testing and linkage to antiretroviral treatment among adults in Africa: a systematic review protocol

A. Boulle, C. Mathews, Damian J. Damian, 2016, Systematic Reviews.

High yield of culture-based diagnosis in a TB-endemic setting

M. Behr, P. V. van Helden, A. Demers, 2012, BMC Infectious Diseases.

Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

M. Egger, G. Maartens, R. Wood, 2007, Antiviral therapy.

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa

A. Boulle, D. Coetzee, E. Goemaere, 2004, AIDS.

The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa

I. Okpechi, A. Boulle, C. Swanepoel, 2019, BMC Nephrology.

The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Failure Time Definition and CD4 Count at Failure.

F. Tanser, R. Wood, M. Davies, 2020, American journal of epidemiology.

Neonatal and infant diagnostic HIV‐PCR uptake and associations during three sequential policy periods in Cape Town, South Africa: a longitudinal analysis

M. Davies, A. Boulle, M. Osler, 2018, Journal of the International AIDS Society.

Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.

R. Wood, J. Skordis, A. Boulle, 2002, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Non‐ignorable loss to follow‐up: correcting mortality estimates based on additional outcome ascertainment

A. Boulle, M. Fox, M. Schomaker, 2014, Statistics in medicine.

Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?

S. Lawn, T. Cohen, M. Mendelson, 2010, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Decreased risk of HIV‐associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population‐based analysis

W. Sikhondze, A. Boulle, I. Ciglenecki, 2019, Tropical medicine & international health : TM & IH.

The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure

M. Egger, B. Eley, R. Wood, 2012, Tropical medicine & international health : TM & IH.

Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy – The IeDEA Southern Africa Collaboration

M. Egger, B. Eley, R. Wood, 2011, Tropical medicine & international health : TM & IH.

Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy

M. Egger, F. Dabis, R. Wood, 2009, Tropical medicine & international health : TM & IH.

Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis

M. Yotebieng, C. Giaquinto, L. Mofenson, 2020, Journal of the International AIDS Society.

Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared

M. Egger, H. Furrer, B. Ledergerber, 2008, PLoS medicine.

A tale of two epidemics within TWO countries.

A. Boulle, C. Kenyon, R. Colebunders, 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa

B. Chi, M. Egger, A. Westfall, 2011, AIDS.

Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol

E. Bateman, M. Bachmann, M. Zwarenstein, 2008, Trials.

Population effect of scaling up ART in resource-poor settings

M. Egger, A. Boulle, 2008, The Lancet.

Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings

M. Egger, E. Delaporte, F. Dabis, 2012, BMC Infectious Diseases.

Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies

M. Egger, O. Keiser, M. Davies, 2009, African journal of AIDS research : AJAR.

The Impact of Same-Day Antiretroviral Therapy Initiation Under the World Health Organization Treat-All Policy

A. Boulle, I. Ciglenecki, M. Schomaker, 2021, American journal of epidemiology.

Tuberculosis and the risk of opportunistic infections and cancers in HIV‐infected patients starting ART in Southern Africa

M. Zwahlen, M. Egger, R. Wood, 2013, Tropical medicine & international health : TM & IH.

Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa

M. Egger, S. Lawn, R. Wood, 2011, Journal of acquired immune deficiency syndromes.

Antiretroviral therapy in resource‐limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub‐Saharan Africa, Asia and Latin America

K. Anastos, L. Myer, M. Egger, 2008, Tropical medicine & international health : TM & IH.

Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study

J. Stringer, M. Egger, T. Hallett, 2013, PloS one.

Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests

T. de Oliveira, J. Bhiman, C. Williamson, 2021, Journal of Virological Methods.

Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa

Leroy, M. Newell, P. Miotti, 2008 .

Consolidating strategic information to monitor progress against the UNAIDS 90–90–90 targets: evaluating the operational feasibility of an electronic HIV testing register in Cape Town, South Africa

J. Hargreaves, A. Boulle, B. Rice, 2020, BMC Health Services Research.

Antiretroviral therapy in resource-poor settings: scaling up inequalities?

M. Egger, P. Miotti, M. Schechter, 1969, International journal of epidemiology.

Autoimmunity predominates in a large South African cohort with Addison's disease of mainly European descent despite long-standing disease and is associated with HLA DQB*0201.

F. Pirie, Ping Yang, Hongjie Wang, 2010, Clinical endocrinology.

Patients lost to care are more likely to be viremic than patients still in care.

N. Ford, A. Boulle, V. Cox, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

G. Rutherford, J. Hargreaves, A. Boulle, 2019, JMIR public health and surveillance.

Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries.

B. Chi, J. Stringer, F. Dabis, 2008, Bulletin of the World Health Organization.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Exploring HIV risk perception and behaviour in the context of antiretroviral treatment: results from a township household survey

N. Ford, M. Boelaert, P. van der Stuyft, 2008, AIDS care.

The importance of identified cause-of-death information being available for public health surveillance, actions and research.

A. Boulle, D. Bradshaw, T. Naledi, 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration

M. Egger, B. Eley, R. Wood, 2013, PloS one.

Virologic Failure and Second-Line Antiretroviral Therapy in Children in South Africa—The IeDEA Southern Africa Collaboration

M. Egger, B. Eley, R. Wood, 2011, Journal of acquired immune deficiency syndromes.

THE BURDEN OF HIV/AIDS IN THE PUBLIC HEALTHCARE SYSTEM

D. Mcintyre, A. Boulle, S. Cleary, 2008 .

Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed

L. Myer, B. Eley, M. Harrison, 2021, AIDS.

Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Africa

N. Ford, A. Boulle, E. Goemaere, 2010, PloS one.

COVID-19 SPECIAL PUBLIC HEALTH SURVEILLANCE BULLETIN Foreword

A. Boulle, 2020 .

Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?

N. Ford, A. Boulle, 2007, Postgraduate Medical Journal.

Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South Africa

R. Parker, I. Bassett, E. Losina, 2020, PloS one.

Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa

A. Boulle, M. Blockman, Annoesjka Swart, 2020, Drug Safety.

Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa

N. Tiffin, A. Boulle, A. Boulle, 2019, International journal of population data science.

Associations With Virologic Treatment Failure in Adults on Antiretroviral Therapy in South Africa

D. Mant, P. Yudkin, A. Boulle, 2010, Journal of acquired immune deficiency syndromes.

Prospects for HIV control in South Africa: a model-based analysis.

L. Myer, L. Bekker, M. Davies, 2016, Global health action.

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study

B. Eley, M. Davies, A. Boulle, 2008, BMC pediatrics.

Self-enrolment antenatal health promotion data as an adjunct to maternal clinical information systems in the Western Cape Province of South Africa

N. Tiffin, P. Barron, A. Boulle, 2018, BMJ Global Health.

Where do HIV-infected adolescents go after transfer? – Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform

B. Eley, R. Wood, N. Tiffin, 2017, Journal of the International AIDS Society.

Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa

L. Myer, M. Davies, A. Boulle, 2020, BMC Pregnancy and Childbirth.

Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?

C. Yiannoutsos, F. Tanser, K. Wools-Kaloustian, 2017, AIDS.

Feasibility of antiretroviral therapy initiation under the treat‐all policy under routine conditions: a prospective cohort study from Eswatini

A. Boulle, I. Ciglenecki, M. Schomaker, 2019, Journal of the International AIDS Society.

Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat‐all approach in rural Eswatini

A. Boulle, I. Ciglenecki, M. Schomaker, 2019, Tropical medicine & international health : TM & IH.

Reflections on a decade of delivering PMTCT in Khayelitsha, South Africa

A. Boulle, D. Coetzee, E. Goemaere, 2014 .

AN EVALUATION OF APPROACHES TO THE INITIATION OF ANTIRETROVIRAL THERAPY DURING PREGNANCY AMONG HIV-INFECTED WOMEN IN CAPE TOWN

L. Myer, A. Boulle, K. Stinson, 2008 .

Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.

A. Boulle, D. Coetzee, E. Goemaere, 2005, Bulletin of the World Health Organization.

Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER)

L. Myer, K. Fieggen, C. Stewart, 2022, BMJ Open.

Why South Africa urgently needs to support the development of pregnancy exposure registries.

H. Rees, A. Boulle, E. Kalk, 2019, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Two-Year Outcomes of Children on Non-Nucleoside Reverse Transcriptase Inhibitor and Protease Inhibitor Regimens in a South African Pediatric Antiretroviral Program

H. Jaspan, A. Boulle, A. Berrisford, 2008, The Pediatric infectious disease journal.

The effect of HIV and antiretroviral treatment on pregnancy rates in the Western Cape province of South Africa.

A. Boulle, L. Johnson, A. Heekes, 2019, The Journal of infectious diseases.

Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data

L. Myer, G. Maartens, M. Davies, 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples.

A. Boulle, D. Coetzee, A. Williamson, 2010, The Journal of general virology.

Anticipating future challenges to ART provision in South Africa : reflections on the Khayelitsha ART programme

A. Boulle, D. Coetzee, 2006 .

Life expectancy trends in adults on antiretroviral treatment in South Africa

F. Tanser, O. Keiser, M. Davies, 2016, AIDS.

Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006–2017

M. Egger, F. Tanser, B. Eley, 2019, The Pediatric infectious disease journal.

countries: what are the benefits and challenges? Scaling up antiretroviral therapy in developing

N. Ford, A. Boulle, 2007 .

Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?

N. Ford, A. Boulle, 2007, Sexually transmitted infections.

Retention among adults initiating antiretroviral therapy in South Africa: 2002-2007.

L. Myer, A. Boulle, M. Cornell, 2011, Journal of acquired immune deficiency syndromes.

Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.

Kara Wools-Kaloustian, Matthias Egger, Paula Braitstein, 2012, International journal of epidemiology.

Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes

J. Sterne, L. Myer, M. Egger, 2010, The Lancet.

Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.

N. Low, M. Egger, F. Dabis, 2008, Journal of women's health.

Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study

M. Egger, A. Boulle, M. Fox, 2013, PloS one.

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

L. Morris, M. Mendelson, G. Maartens, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

J. Sterne, M. Egger, F. Dabis, 2006, The Lancet.

COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce.

M. Davies, A. Boulle, M. Paleker, 2022, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals

N. Ford, J. Eaton, P. Ehrenkranz, 2021, PLoS medicine.

The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis

D. Mcintyre, A. Boulle, S. Cleary, 2006, Cost effectiveness and resource allocation : C/E.

Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.

M. Egger, B. Eley, R. Wood, 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Inequality in outcomes for adolescents living with perinatally acquired HIV in sub‐Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis

M. Yotebieng, S. Ayaya, R. Sahabo, 2018, Journal of the International AIDS Society.

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

G. Maartens, A. Boulle, D. Coetzee, 2008, JAMA.

Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Suppression: Five-Year Follow Up of an Observational Cohort

N. Ford, E. Mills, A. Boulle, 2010, PloS one.

Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy

A. Boulle, D. Coetzee, E. Goemaere, 2015, Journal of the International AIDS Society.

20th Conference on Retroviruses and Opportunistic Infections, Atlanta, USA

J. Sterne, M. Egger, M. May, 2013 .

The effeciveness and determinants of effectiveness of antiretroviral therapy for adults in the Western Cape Province, South Africa

A. Boulle, 2009 .

Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial

K. Barnes, A. Boulle, E. Allen, 2009, Malaria Journal.

CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy: Multicohort Analysis From South Africa

M. Egger, R. Wood, C. Hoffmann, 2013, Journal of acquired immune deficiency syndromes.

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring

M. Egger, F. Dabis, P. Braitstein, 2009, AIDS.

Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa

N. Longley, N. Govender, A. Boulle, 2016, Journal of acquired immune deficiency syndromes.

Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.

L. Myer, M. Egger, A. Boulle, 2013, Journal of clinical epidemiology.

Provision of antiretroviral therapy to children within the public sector of South Africa.

B. Eley, A. Boulle, M. Osler, 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis

N. Ford, E. Mills, S. Mookerjee, 2012, AIDS.

Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial

Max O Bachmann, Eduan Kotze, Simon Lewin, 2012, The Lancet.

Prognosis of Children With HIV-1 Infection Starting Antiretroviral Therapy in Southern Africa: A Collaborative Analysis of Treatment Programs

M. Egger, B. Eley, R. Wood, 2014, The Pediatric infectious disease journal.

Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration.

F. Dabis, M. Cotton, M. Newell, 2008, International journal of epidemiology.

Effectiveness of antiretroviral treatment in a South African program: a cohort study.

E. Bateman, M. Bachmann, M. Zwarenstein, 2008, Archives of internal medicine.

Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa

M. Hernán, J. Sterne, M. Egger, 2012, Journal of acquired immune deficiency syndromes.

Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland

B. Chi, J. Stringer, M. Egger, 2011, PloS one.

Attrition from HIV care among youth initiating ART in youth‐only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis

A. Boulle, M. Fox, T. Cassidy, 2022, Journal of the International AIDS Society.

The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring

M. Maathuis, B. Chi, M. Petersen, 2012, AIDS.

Mortality after failure of antiretroviral therapy in sub‐Saharan Africa

M. Egger, F. Dabis, P. Braitstein, 2010, Tropical medicine & international health : TM & IH.

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission

F. Tanser, B. Eley, R. Wood, 2020, PloS one.

What Should we do When HIV-Positive Children Fail First-Line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.

M. Egger, F. Tanser, B. Eley, 2019, The Pediatric infectious disease journal.

The Impact of Same-Day Antiretroviral Therapy Initiation Under the World Health Organization Treat-All Policy

A. Boulle, I. Ciglenecki, M. Schomaker, 2020, American journal of epidemiology.

The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure

F. Tanser, R. Wood, M. Davies, 2019, bioRxiv.

Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression

N. Ford, L. Mofenson, F. Tanser, 2015, The Pediatric infectious disease journal.

How should access to antiretroviral treatment be measured?

A. Boulle, L. Johnson, 2011, Bulletin of the World Health Organization.

Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa.

B. Eley, A. Sohn, C. Chimbetete, 2020, AIDS.

Utility of digitising point of care HIV test results to accurately measure, and improve performance towards, the UNAIDS 90-90-90 targets

J. Hargreaves, A. Boulle, B. Rice, 2020, PloS one.

Commentary: Reducing HIV-associated tuberculosis in children.

B. Eley, A. Boulle, 2009, International journal of epidemiology.

Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.

L. Myer, M. Egger, F. Tanser, 2015, The lancet. HIV.

Orphans of the AIDS epidemic? The extent, nature and circumstances of child-headed households in South Africa

A. Boulle, K. Hall, H. Meintjes, 2009, AIDS care.

Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes

M. Vinikoor, R. Wood, G. Wandeler, 2017, Journal of acquired immune deficiency syndromes.

Provision of Antiretroviral Therapy in South Africa: The Nuts and Bolts

L. Bekker, R. Wood, A. Boulle, 2014, Antiviral therapy.

Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa

M. Hernán, N. Ford, A. Boulle, 2013, PloS one.

High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: A model of care in Khayelitsha, South Africa

N. Ford, A. Boulle, E. Goemaere, 2013 .

Patterns of HIV, TB, and non-communicable disease multi-morbidity in an informal peri-urban setting in Cape Town, South Africa

N. McGrath, R. Wilkinson, A. Boulle, 2015 .

A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings

N. Ford, A. Boulle, E. Goemaere, 2014, Journal of the International AIDS Society.

Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies

Michael Schomaker, Peter Reiss, Amy C. Justice, 2014, PLoS medicine.

Immune Recovery After Starting ART in HIV-Infected Patients Presenting and Not Presenting With Tuberculosis in South Africa

M. Egger, C. Hoffmann, A. Boulle, 2013, Journal of acquired immune deficiency syndromes.

Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, J. Sterne, K. Anastos, 2013, Journal of acquired immune deficiency syndromes.

Assessing rates and contextual predictors of 5-year mortality among HIV-infected and HIV-uninfected individuals following HIV testing in Durban, South Africa

R. Parker, I. Bassett, E. Losina, 2019, BMC Infectious Diseases.

Cost-effectiveness of antiretroviral treatment for HIV-positive adults in a South African township.

D. Mcintyre, A. Boulle, D. Coetzee, 2004 .

“I don't use a condom (with my regular partner) because I know that I'm faithful, but with everyone else I do”: The cultural and socioeconomic determinants of sexual partner concurrency in young South Africans

A. Boulle, C. Kenyon, M. Badri, 2010, SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance.

Is it safe to drop CD4+ monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa.

N. Ford, M. Davies, A. Boulle, 2014, AIDS.

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.

L. Myer, A. Mocroft, M. Egger, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Auditing chronic disease care: Does it make a difference?

A. Boulle, E. de Vries, A. Schlemmer, 2012, African journal of primary health care & family medicine.

A network-level explanation for the differences in HIV prevalence in South Africa's racial groups

R. White, A. Boulle, C. Kenyon, 2009, African journal of AIDS research : AJAR.

The effect of a mobile phone peer -to-peer mentorship program for newly diagnosed HIV positive youth in Khayelitsha, South Africa: a mixed methods study. (Preprint)

A. Boulle, T. Cassidy, D. Hacking, 2019 .

Prognosis of HIV-1-infected Patients Starting ART in Sub-Saharan Africa: A Collaborative Analysis of Scale-up Programs

Western, J. Sterne, L. Myer, 2010 .

Pharmacovigilance: A public health priority for South Africa.

H. Rees, A. Boulle, K. Cohen, 2017, South African health review.

Feasibility of an HIV self-testing intervention: a formative qualitative study among individuals, community leaders, and HIV testing experts in northern Tanzania

A. Boulle, C. Mathews, Damian J. Damian, 2020, BMC Public Health.

Coverage of the Prevention of Mother-to-Child Transmission Program in the Western Cape, South Africa Using Cord Blood Surveillance

J. Stringer, A. Boulle, D. Coetzee, 2012, Journal of acquired immune deficiency syndromes.

A systematic review of qualitative evidence on factors enabling and deterring uptake of HIV self-testing in Africa

A. Boulle, C. Mathews, Damian J. Damian, 2019, BMC Public Health.

A Review of Antiretroviral Costing Models in South Africa

A. Boulle, C. Kenyon, F. Abdullah, 2003 .

Antiretroviral therapy and early mortality in South Africa.

Karen Cohen, Peter Bock, A. Boulle, 2008, Bulletin of the World Health Organization.

Peer Mentorship via Mobile Phones for Newly Diagnosed HIV-Positive Youths in Clinic Care in Khayelitsha, South Africa: Mixed Methods Study

A. Boulle, T. Cassidy, D. Hacking, 2019, Journal of medical Internet research.

Higher COVID-19 mortality in low-income communities in the City of Cape Town – a descriptive ecological study

L. London, M. Davies, A. Boulle, 2021, Gates open research.

Trends in maternal and neonatal mortality in South Africa: a systematic review

A. Boulle, S. Msuya, Damian J. Damian, 2019, Systematic Reviews.

The Effect of Complete Integration of HIV and TB Services on Time to Initiation of Antiretroviral Therapy: A Before-After Study

A. Boulle, D. Coetzee, E. Goemaere, 2012, PloS one.

Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia

T. Bärnighausen, F. Tanser, R. Wood, 2018, American journal of epidemiology.

HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies

M. Zwahlen, M. Egger, H. Furrer, 2017, Journal of the International AIDS Society.

Commentary: Factors affecting HIV/AIDS-related stigma and discrimination by medical professionals.

A. Boulle, H. Deacon, 2007, International journal of epidemiology.

Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis

Thomas Gsponer, Gilles Wandeler, Matthias Egger, 2012, AIDS.

Elevation and cholera: an epidemiological spatial analysis of the cholera epidemic in Harare, Zimbabwe, 2008-2009

Michael Schomaker, Peter Maes, J. Fesselet, 2012, BMC Public Health.

Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa

L. Myer, A. Boulle, D. Coetzee, 2010, Tropical medicine & international health : TM & IH.

Trends in maternal and neonatal mortality in South Africa: a systematic review protocol

A. Boulle, S. Msuya, Damian J. Damian, 2017, Systematic Reviews.

THE COST, CAUSE AND PLACE OF DEATH IN PATIENTS DYING WITH HIV/AIDS AND WHO HAVE ACCESS TO ART

A. Boulle, 2013 .

Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes

M. Zwahlen, M. Egger, C. Chimbetete, 2018, BMJ Open.

Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis

R. Wood, A. Boulle, J. Caldwell, 2015, Journal of the International AIDS Society.

Twelve-year mortality in adults initiating antiretroviral therapy in South Africa

M. Egger, F. Tanser, R. Wood, 2017, Journal of the International AIDS Society.

diabetes : A virtual cohort study from theWestern Cape Province , South Africa

N. Tiffin, M. Davies, A. Boulle, 2021 .

Cochrane Column.

C. Wiysonge, A. Boulle, T. Kredo, 2015, International journal of epidemiology.

A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa

M. Davies, A. Boulle, M. Osler, 2020, Journal of the International AIDS Society.

Evaluation of a public COVID-19 dashboard in the Western Cape, South Africa: a tool for communication, trust, and transparency

M. Davies, A. Boulle, M. Paleker, 2022, BMC Public Health.

Digitising point of care HIV test results to accurately measure, and improve performance towards, the UNAIDS 90-90-90 targets

J. Hargreaves, A. Boulle, B. Rice, 2019 .

Khayelitsha 2001 - 2011: 10 years of primary care HIV and TB programmes

A. Boulle, D. Coetzee, E. Goemaere, 2011 .

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

G. Gottlieb, J. Stringer, C. Yiannoutsos, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Accounting for and responding to HIV-associated mortality.

N. Ford, M. Egger, A. Boulle, 2015, AIDS.

Tuberculosis in HIV programmes in lower-income countries: practices and risk factors.

M. Egger, F. Dabis, P. Braitstein, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Safety and Effectiveness of Isoniazid Preventive Therapy in HIV-Positive Pregnant Women on Art: An Observational Study using Linked Population Data.

L. Myer, G. Maartens, M. Davies, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study

B. Eley, M. Davies, A. Boulle, 2008 .

Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings

B. Chi, M. Egger, M. Law, 2015, Journal of acquired immune deficiency syndromes.

Cost Effectiveness and Resource Allocation Open Access the Cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a Primary Data Analysis

D. Mcintyre, A. Boulle, S. Cleary, 2022 .

Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa

G. Rutherford, M. Egger, J. Hargreaves, 2018, JMIR public health and surveillance.

Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial

E. Bateman, M. Bachmann, M. Zwarenstein, 2012, The Lancet.

Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?

C. Yiannoutsos, F. Tanser, K. Wools-Kaloustian, 2017, AIDS.